Vertex Pharmaceuticals Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 11/13/2025 | 25.91 M | $10.15 B | -9.82% | 10.09% |
| VANGUARD GROUP INC | 11/07/2025 | 24.22 M | $9.48 B | 1.01% | 9.43% |
| BLACKROCK, INC. | 11/12/2025 | 22.25 M | $8.72 B | 1.74% | 8.67% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2025 | 16.55 M | $6.48 B | 2.76% | 6.45% |
| STATE STREET CORP | 11/14/2025 | 11.61 M | $4.55 B | -1.44% | 4.52% |
| JPMORGAN CHASE & CO | 11/26/2025 | 6.43 M | $2.52 B | 9.63% | 2.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 5.97 M | $2.33 B | 0.76% | 2.33% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 4.77 M | $1.87 B | -0.86% | 1.86% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 4.69 M | $1.84 B | 77.89% | 1.83% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 4.52 M | $1.77 B | 3.30% | 1.76% |
| LOOMIS SAYLES & CO L P | 11/13/2025 | 4.12 M | $1.61 B | 8.10% | 1.61% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 3.45 M | $1.35 B | -43.84% | 1.35% |
| FMR LLC | 11/13/2025 | 3.30 M | $1.29 B | -48.43% | 1.29% |
| MORGAN STANLEY | 11/14/2025 | 3.11 M | $1.22 B | -6.69% | 1.21% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 3.04 M | $1.19 B | -3.67% | 1.19% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 2.89 M | $1.13 B | -5.88% | 1.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 2.84 M | $1.11 B | 1.17% | 1.11% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/13/2025 | 2.65 M | $1.04 B | 73.17% | 1.03% |
| NORTHERN TRUST CORP | 11/14/2025 | 2.63 M | $1.03 B | -1.15% | 1.02% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 2.28 M | $891.74 M | 4.38% | 0.89% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 2.25 M | $787.32 M | 4.29% | 0.88% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 2.12 M | $829.90 M | -19.10% | 0.83% |
| INVESCO LTD. | 11/13/2025 | 2.10 M | $821.19 M | 5.68% | 0.82% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 1.95 M | $764.60 M | 3.31% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.83 M | $716.67 M | 3.17% | 0.71% |
| PARNASSUS INVESTMENTS, LLC | 10/24/2025 | 1.65 M | $645.59 M | -3.68% | 0.64% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.60 M | $626.80 M | 13.70% | 0.62% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 1.57 M | $614.55 M | -1.96% | 0.61% |
| EDGEWOOD MANAGEMENT LLC | 11/12/2025 | 1.49 M | $582.58 M | -39.41% | 0.58% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.48 M | $581.45 M | -23.14% | 0.58% |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 11/14/2025 | 1.34 M | $525.37 M | 11.25% | 0.52% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.19 M | $467.51 M | -13.77% | 0.47% |
| WCM INVESTMENT MANAGEMENT, LLC | 11/04/2025 | 1.15 M | $454.66 M | -1.16% | 0.45% |
| AMUNDI | 11/14/2025 | 1.12 M | $450.83 M | -1.26% | 0.44% |
| NUVEEN, LLC | 11/12/2025 | 1.08 M | $422.07 M | 1.46% | 0.42% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 791.46 K | $310.50 M | 7.56% | 0.31% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 783.59 K | $306.91 M | 31.42% | 0.31% |
| UBS GROUP AG | 11/13/2025 | 773.05 K | $302.76 M | 10.44% | 0.30% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 763.70 K | $299.10 M | 214.60% | 0.30% |
| BARCLAYS PLC | 11/12/2025 | 742.49 K | $290.79 M | -9.78% | 0.29% |
| SWISS NATIONAL BANK | 11/13/2025 | 740.30 K | $289.93 M | -4.88% | 0.29% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 735.89 K | $288.20 M | -26.77% | 0.29% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 717.33 K | $280.93 M | 2.18% | 0.28% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 10/27/2025 | 700.67 K | $274.41 M | 6.96% | 0.27% |
| HSBC HOLDINGS PLC | 11/13/2025 | 637.33 K | $249.45 M | -0.72% | 0.25% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 11/14/2025 | 612.51 K | $239.88 M | -15.52% | 0.24% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 607.84 K | $238.05 M | 245.98% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 596.80 K | $233.73 M | 23.66% | 0.23% |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 11/12/2025 | 544.98 K | $213.44 M | 3.82% | 0.21% |
| LAZARD ASSET MANAGEMENT LLC | 11/14/2025 | 544.82 K | $213.37 M | 13.43% | 0.21% |
Vertex Pharmaceuticals Incorporated institutional Ownership - FAQ's
During the previous two years, 2171 institutional investors and hedge funds held shares of Vertex Pharmaceuticals Incorporated. The most heavily invested institutionals were:
Capital World Investors: 25.91 M
VANGUARD GROUP INC: 24.22 M
BlackRock, Inc.: 22.25 M
Capital Research Global Investors: 16.55 M
STATE STREET CORP: 11.61 M
JPMORGAN CHASE & CO: 6.43 M
90.31% of Vertex Pharmaceuticals Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 300.04 M shares in the last 24 months. This purchase volume represents approximately $137.25 B in transactions.